Updates on the Management of Gastrointestinal Stromal Tumors
- 30 April 2012
- journal article
- review article
- Published by Elsevier BV in Surgical Oncology Clinics of North America
- Vol. 21 (2), 301-316
- https://doi.org/10.1016/j.soc.2011.12.004
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumorsGenes, Chromosomes and Cancer, 2008
- Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumorsProceedings of the National Academy of Sciences of the United States of America, 2008
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Imatinib Mesylate — A New Oral Targeted TherapyThe New England Journal of Medicine, 2002
- KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorThe New England Journal of Medicine, 2001
- The histopathological differential diagnosis of gastrointestinal stromal tumoursJournal of Clinical Pathology, 2001
- Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.2000
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000